Aging facilities have become a concern in the pharmaceutical and biopharmaceutical
manufacturing industry, so much that task forces are formed by trade organizations to …

The pharmaceutical industry has the reputation of being cautious about implementing new
technology and slow to make changes. This conservatism is due, at least in part, to …

Aging equipment has long been a reality in the chemical process industries. Plants built in
the 1950s and 1960s, during an age of prosperity and growth, have since surpassed their …

Maintenance and service-related items are often the second-largest budget element in a
laboratory after salaries and benefits. Within maintenance, preventive maintenance (PM) is a …

A high-quality drug is generally considered one that is free of contamination and that reliably
delivers to the patient the therapeutic benefit as promised on the product label. When …

Pharmaceutical companies increasingly are working to improve productivity and reduce
costs in their manufacturing and packaging operations. Expanding markets and innovative …

Post-approval changes are inevitable and necessary throughout the life of a drug product—
to implement new knowledge, maintain a state of control, and drive continual improvement …

Commissioning is the planning, coordination, management, and execution of activities that
form the bridge between the construction phase and the operation and maintenance phase …

This white paper focuses on equipment, and analytical manufacturers' perspectives,
regarding the challenges of continuous pharmaceutical manufacturing across five prompt …

Change is inevitable in a pharmaceutical manufacturing operation. Vendors change
processes, sources, and specifications for raw materials, equipment requires repair, service …